Skip to main content

letter

. 1990 Sep;83(9):598–599. doi: 10.1177/014107689008300926

Pyrimethamine-sulphadoxine: how great the risk?

PMCID: PMC1292831 PMID: 2213817

599

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Coole L., Wiselka M. J., Nicholson K. G. Malaria prophylaxis in travellers from Britain. J Infect. 1989 May;18(3):209–212. doi: 10.1016/s0163-4453(89)80056-8. [DOI] [PubMed] [Google Scholar]
Gottlieb M. S., Knight S., Mitsuyasu R., Weisman J., Roth M., Young L. S. Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine. Lancet. 1984 Aug 18;2(8399):398–399. doi: 10.1016/s0140-6736(84)90560-9. [DOI] [PubMed] [Google Scholar]
Hohlfeld P., Daffos F., Thulliez P., Aufrant C., Couvreur J., MacAleese J., Descombey D., Forestier F. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr. 1989 Nov;115(5 Pt 1):765–769. doi: 10.1016/s0022-3476(89)80660-2. [DOI] [PubMed] [Google Scholar]
McCabe R. E., Oster S. Current recommendations and future prospects in the treatment of toxoplasmosis. Drugs. 1989 Dec;38(6):973–987. doi: 10.2165/00003495-198938060-00008. [DOI] [PubMed] [Google Scholar]
Pape J. W., Verdier R. I., Johnson W. D., Jr Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1989 Apr 20;320(16):1044–1047. doi: 10.1056/NEJM198904203201604. [DOI] [PubMed] [Google Scholar]
Rombo L., Stenbeck J., Lobel H. O., Campbell C. C., Papaioanou M., Miller K. D. Does chloroquine contribute to the risk of serious adverse reactions to fansidar? Lancet. 1985 Dec 7;2(8467):1298–1299. doi: 10.1016/s0140-6736(85)91574-0. [DOI] [PubMed] [Google Scholar]
Stahel E., Druilhe P., Gentilini M. Antagonism of chloroquine with other antimalarials. Trans R Soc Trop Med Hyg. 1988;82(2):221–221. doi: 10.1016/0035-9203(88)90417-8. [DOI] [PubMed] [Google Scholar]
Steffen R., Somaini B. Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland. Lancet. 1986 Mar 15;1(8481):610–610. doi: 10.1016/s0140-6736(86)92825-4. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES